Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Mean (and standard error) length of stay on shore relative to the length of the open water season, defined as when the proportion of the continental shelf covered by >15% sea ice c... by Todd C. Atwood (683595)

White matter maps showing regions of significant decreased fractional anisotropy and increased mean diffusivity in MSA patients when compared to healthy controls and PD (Bonferroni... by Amanda Worker (662839)

Relative changes (in %) in biomasses, yields, and mean body sizes (individuals above 2 cm length) in model groups across the alternative model scenarios with increasing or decreasi... by Asta Audzijonyte (3250995)

Prevalence of antimicrobial resistance to folate pathway inhibitors exhibits a decreasing linear trend from 2002–2016. by Kelly E. Davidson (5464472)

WNF decreases Aβ peptides generation in HEK293 and SH-SY5Y human cells. by Htut Htut Htoo (3686641)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Drive dynamics for split^<50cM <i>ClvR</i>s with different genetic linkage and migration rates. by Georg Oberhofer (3401438)

The radial water maze latency [s (mean ± SEM)] and number of errors (mean ± SEM) of proton irradiated and control rats on Day 1 and Day 2. by Michael T. Williams (357796)

Study characteristics. by Luke R. Arieta (10517126)

Subjects:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. by Luke R. Arieta (10517126)

Subjects:

Overall effects for pH. by Luke R. Arieta (10517126)

Subjects:

Effect of contraction mode on pH. by Luke R. Arieta (10517126)

Subjects:

Overall effects for inorganic phosphate. by Luke R. Arieta (10517126)

Subjects:

Effect of contraction mode on inorganic phosphate. by Luke R. Arieta (10517126)

Subjects:

The process of selecting participants. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

C-indexes for the nomograms. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

Decreased K^trans with cediranib/SC68896 treatment is largely related to decreased rCBV and vessel surface area. by Merryl R. Lobo (672130)

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

“…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…”

Temporal changes in the RPR titer from before to after treatment. by Kazuhiko Ikeuchi (9234268)